These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 22179430

  • 1. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K, Róka R, Séra T, Rosztóczy A, Annaházi A, Izbéki F, Nagy F, Molnár T, Szepes Z, Pávics L, Bueno L, Wittmann T.
    Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
    [Abstract] [Full Text] [Related]

  • 2. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC.
    Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY, Huang SG, Zhang HY, Ye H, Chi HG, Zou Y, Lv RX, Zheng XB.
    World J Gastroenterol; 2016 Mar 28; 22(12):3451-9. PubMed ID: 27022227
    [Abstract] [Full Text] [Related]

  • 4. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L.
    Clin Gastroenterol Hepatol; 2007 May 28; 5(5):550-5. PubMed ID: 17336590
    [Abstract] [Full Text] [Related]

  • 5. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L.
    Gut; 2008 May 28; 57(5):591-9. PubMed ID: 18194983
    [Abstract] [Full Text] [Related]

  • 6. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
    Li MR, Jiang K, Zhang QY.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):957-60. PubMed ID: 18756966
    [Abstract] [Full Text] [Related]

  • 7. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G.
    Am J Gastroenterol; 2009 Feb 08; 104(2):392-400. PubMed ID: 19174797
    [Abstract] [Full Text] [Related]

  • 8. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.
    Rao AS, Camilleri M, Eckert DJ, Busciglio I, Burton DD, Ryks M, Wong BS, Lamsam J, Singh R, Zinsmeister AR.
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov 08; 301(5):G919-28. PubMed ID: 21836056
    [Abstract] [Full Text] [Related]

  • 9. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA.
    Gastroenterology; 2006 Jan 08; 130(1):34-43. PubMed ID: 16401466
    [Abstract] [Full Text] [Related]

  • 10. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ, Kunkel D, Low K, Conklin JL, Pimentel M.
    J Clin Gastroenterol; 2011 Oct 08; 45(9):790-3. PubMed ID: 21301356
    [Abstract] [Full Text] [Related]

  • 11. Ulcerative colitis and irritable bowel syndrome: relationships with quality of life.
    Ansari R, Attari F, Razjouyan H, Etemadi A, Amjadi H, Merat S, Malekzadeh R.
    Eur J Gastroenterol Hepatol; 2008 Jan 08; 20(1):46-50. PubMed ID: 18090990
    [Abstract] [Full Text] [Related]

  • 12. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
    Katinios G, Casado-Bedmar M, Walter SA, Vicario M, González-Castro AM, Bednarska O, Söderholm JD, Hjortswang H, Keita ÅV.
    Inflamm Bowel Dis; 2020 Jun 18; 26(7):974-984. PubMed ID: 31944236
    [Abstract] [Full Text] [Related]

  • 13. Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions.
    Bassotti G, de Roberto G, Chistolini F, Sietchiping-Nzepa F, Morelli O, Morelli A.
    Int J Colorectal Dis; 2004 Sep 18; 19(5):493-7. PubMed ID: 15083326
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome.
    Ng C, Danta M, Kellow J, Badcock CA, Hansen R, Malcolm A.
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep 18; 289(3):G489-94. PubMed ID: 15905412
    [Abstract] [Full Text] [Related]

  • 15. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M.
    Gastroenterology; 2009 Oct 18; 137(4):1425-34. PubMed ID: 19596012
    [Abstract] [Full Text] [Related]

  • 16. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC.
    J Gastroenterol Hepatol; 2006 Jan 18; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [Abstract] [Full Text] [Related]

  • 17. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
    Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L, Eutamene H.
    Pain; 2009 Jul 18; 144(1-2):209-17. PubMed ID: 19450926
    [Abstract] [Full Text] [Related]

  • 18. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A, Chojnacki J, Wiśiewska-Jarosińska M, Stec-Michalska K, Szadkowski K, Smigielski J, Chojnacki C.
    Pol Merkur Lekarski; 2007 May 18; 22(131):366-8. PubMed ID: 17679369
    [Abstract] [Full Text] [Related]

  • 19. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M.
    Gut; 2009 Feb 18; 58(2):196-201. PubMed ID: 18824556
    [Abstract] [Full Text] [Related]

  • 20. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V, Hébuterne X, Piche T.
    Gut; 2014 May 18; 63(5):744-52. PubMed ID: 23878165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.